DaVita Shares Outstanding 2010-2024 | DVA

DaVita shares outstanding history from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • DaVita shares outstanding for the quarter ending September 30, 2024 were 0.086B, a 8.77% decline year-over-year.
  • DaVita 2023 shares outstanding were 0.093B, a 2.77% decline from 2022.
  • DaVita 2022 shares outstanding were 0.096B, a 12.84% decline from 2021.
  • DaVita 2021 shares outstanding were 0.11B, a 10.34% decline from 2020.
DaVita Annual Shares Outstanding
(Millions of Shares)
2023 93
2022 96
2021 110
2020 123
2019 154
2018 172
2017 191
2016 205
2015 216
2014 217
2013 215
2012 196
2011 193
2010 206
2009 208
DaVita Quarterly Shares Outstanding
(Millions of Shares)
2024-09-30 86
2024-06-30 89
2024-03-31 91
2023-12-31 93
2023-09-30 94
2023-06-30 93
2023-03-31 92
2022-12-31 96
2022-09-30 93
2022-06-30 98
2022-03-31 101
2021-12-31 110
2021-09-30 110
2021-06-30 111
2021-03-31 114
2020-12-31 123
2020-09-30 124
2020-06-30 124
2020-03-31 127
2019-12-31 154
2019-09-30 151
2019-06-30 167
2019-03-31 167
2018-12-31 172
2018-09-30 167
2018-06-30 174
2018-03-31 182
2017-12-31 191
2017-09-30 191
2017-06-30 194
2017-03-31 195
2016-12-31 205
2016-09-30 207
2016-06-30 208
2016-03-31 208
2015-12-31 216
2015-09-30 217
2015-06-30 218
2015-03-31 213
2014-12-31 217
2014-09-30 217
2014-06-30 217
2014-03-31 216
2013-12-31 215
2013-09-30 215
2013-06-30 215
2013-03-31 214
2012-12-31 196
2012-09-30 193
2012-06-30 192
2012-03-31 191
2011-12-31 193
2011-09-30 190
2011-06-30 195
2011-03-31 197
2010-12-31 206
2010-09-30 208
2010-06-30 209
2010-03-31 210
2009-12-31 208
2009-09-30 209
2009-06-30 208
2009-03-31 209
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $12.060B $12.140B
DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.921B 12.66
Quest Diagnostics (DGX) United States $17.320B 17.55
Encompass Health (EHC) United States $10.267B 24.21
Chemed (CHE) United States $8.277B 25.44
Elanco Animal Health (ELAN) United States $6.357B 14.29
RadNet (RDNT) United States $5.166B 122.54
Option Care Health (OPCH) United States $3.999B 18.95
Amedisys (AMED) United States $3.199B 22.78
Astrana Health (ASTH) United States $2.920B 41.31
LifeStance Health (LFST) United States $2.728B 0.00
Addus HomeCare (ADUS) United States $2.375B 27.86
U.S Physical Therapy (USPH) United States $1.464B 38.53
Pennant (PNTG) United States $1.004B 46.00
Aveanna Healthcare Holdings (AVAH) United States $0.929B 0.00
Atai Life Sciences (ATAI) Germany $0.198B 0.00
Daxor (DXR) United States $0.047B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.013B 0.00
Ontrak (OTRK) United States $0.007B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00